David Weinreich

Directeur Technique/Scientifique/R&D chez MERCK KGAA

Health Technology

Consumer Services

Finance

Profil

David is an operating partner at Foresite Labs, and also serves as senior advisor at Foresite Capital.
With more than 20 years of expertise in clinical development, drug commercialization and advancing therapies for patients in need, David supports Foresite Labs’ incubated companies, particularly their translational and clinical research commitments, and explores and initiates new programs and company concepts.
David joined Foresite Labs from Regeneron, where he was the executive vice president and head of global clinical development.
During his tenure with the company, David managed programs across different therapeutic focus areas, including its successful Dupixent program and its COVID therapeutic antibody.
Prior to Regeneron, he was the head of global development for specialty medicine at Bayer Pharmaceuticals and previously served as executive director and global product area leader (Angiogenesis) at Amgen.
BS in Computer Engineering from Columbia University Executive MBA from Georgetown University MD from Boston University School of Medicine

Postes actifs de David Weinreich

Sociétés	Poste	Début
MERCK KGAA	Directeur Technique/Scientifique/R&D	28/08/2025

Tous les postes actifs de David Weinreich

Anciens postes connus de David Weinreich

Sociétés	Poste	Fin
Foresite Capital Management LLC Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the US. The firm focuses on companies operating across a broad range of sectors. It provides financing for seed and later stage capital requirements.	Consultant / Advisor	01/07/2025
Foresite Labs LLC Foresite Labs LLC Miscellaneous Commercial ServicesCommercial Services Provides incubation platform services	Private Equity Investor	01/07/2025
REGENERON PHARMACEUTICALS, INC.	Private Equity Investor	01/08/2023
Bayer Pharmaceuticals Corp.	Private Equity Investor	01/02/2016
AMGEN INC.	Private Equity Investor	01/06/2012

Voir l'expérience en détail de David Weinreich

Formation de David Weinreich

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Weinreich

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	10
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases	Health Technology
Merck KGaA Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products	Health Technology
Gene Logic, Inc. Gene Logic, Inc. BiotechnologyHealth Technology Develops and discovers pharmaceutical	Health Technology
Bayer Pharmaceuticals Corp.
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Georgetown University Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Foresite Capital Management LLC Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the US. The firm focuses on companies operating across a broad range of sectors. It provides financing for seed and later stage capital requirements.	Finance
Boston University School of Medicine Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Foresite Labs LLC Foresite Labs LLC Miscellaneous Commercial ServicesCommercial Services Provides incubation platform services	Commercial Services